Inhibikase Therapeutics, Inc. (IKT)
 NASDAQ: IKT · Real-Time Price · USD
 1.460
 0.00 (0.00%)
  Oct 31, 2025, 10:35 AM EDT - Market open
Inhibikase Therapeutics Market Cap
Inhibikase Therapeutics has a market cap or net worth of $108.79 million as of October 31, 2025. Its market cap has increased by 616.26% in one year.
Market Cap 
 108.79M
Enterprise Value 
 21.17M
1-Year Change 
 616.26%
Ranking 
 Category 
 Stock Price 
$1.46
Market Cap Chart
Since the IPO on December 23, 2020, Inhibikase Therapeutics's market cap has increased from $100.46M to $108.79M, an increase of 8.30%. That is a compound annual growth rate of 1.66%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 108.79M | -50.18% | 
| Dec 31, 2024 | 218.38M | 2,684.93% | 
| Dec 29, 2023 | 7.84M | -37.83% | 
| Dec 30, 2022 | 12.61M | -65.89% | 
| Dec 31, 2021 | 36.98M | -46.68% | 
| Dec 31, 2020 | 69.35M | -30.96% | 
| Dec 23, 2020 | 100.46M | - | 
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 731.65B | 
| Johnson & Johnson | 449.95B | 
| AbbVie | 401.32B | 
| UnitedHealth Group | 337.95B | 
| AstraZeneca | 259.35B | 
| Novartis AG | 250.89B | 
| Novo Nordisk | 235.38B | 
| Abbott Laboratories | 220.22B |